NO951775D0 - Nye 3,3-difenylpropylaminer, deres anvendelse og fremstilling - Google Patents
Nye 3,3-difenylpropylaminer, deres anvendelse og fremstillingInfo
- Publication number
- NO951775D0 NO951775D0 NO951775A NO951775A NO951775D0 NO 951775 D0 NO951775 D0 NO 951775D0 NO 951775 A NO951775 A NO 951775A NO 951775 A NO951775 A NO 951775A NO 951775 D0 NO951775 D0 NO 951775D0
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- diphenylpropylamines
- methyl
- preparation
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Luminescent Compositions (AREA)
- Photoreceptors In Electrophotography (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9203318A SE9203318D0 (sv) | 1992-11-06 | 1992-11-06 | Novel 3,3-diphenylpropylamines, their use and preparation |
PCT/SE1993/000927 WO1994011337A1 (en) | 1992-11-06 | 1993-11-05 | Novel 3,3-diphenylpropylamines, their use and preparation |
Publications (3)
Publication Number | Publication Date |
---|---|
NO951775D0 true NO951775D0 (no) | 1995-05-05 |
NO951775L NO951775L (no) | 1995-05-05 |
NO305477B1 NO305477B1 (no) | 1999-06-07 |
Family
ID=20387730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO951775A NO305477B1 (no) | 1992-11-06 | 1995-05-05 | Nye 3,3-difenylpropylaminer, farmas°ytiske preparater inneholdende slike forbindelser, og deres anvendelse |
Country Status (15)
Country | Link |
---|---|
US (4) | USRE39667E1 (no) |
EP (1) | EP0667852B1 (no) |
JP (1) | JP3343256B2 (no) |
AT (1) | ATE164828T1 (no) |
AU (1) | AU672458B2 (no) |
CA (1) | CA2148827C (no) |
DE (1) | DE69317898T2 (no) |
DK (1) | DK0667852T3 (no) |
ES (1) | ES2117155T3 (no) |
FI (1) | FI120256B (no) |
HK (1) | HK1006349A1 (no) |
HU (1) | HU224916B1 (no) |
NO (1) | NO305477B1 (no) |
SE (1) | SE9203318D0 (no) |
WO (1) | WO1994011337A1 (no) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9203318D0 (sv) | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
WO1998000140A1 (en) * | 1996-07-01 | 1998-01-08 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence using enantiomerically enriched (r)-trihexyphenidyl |
AU733209B2 (en) * | 1996-12-02 | 2001-05-10 | Kyorin Pharmaceutical Co. Ltd. | Novel n-substituted pyrrolidine derivatives and process for preparing the same |
SE9701144D0 (sv) * | 1997-03-27 | 1997-03-27 | Pharmacia & Upjohn Ab | Novel compounds, their use and preparation |
EP0957073A1 (en) | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
US6770295B1 (en) | 1998-08-27 | 2004-08-03 | Pharmacia Ab | Therapeutic formulation for administering tolterodine with controlled release |
CA2387973C (en) | 1999-11-11 | 2009-12-22 | Pharmacia Ab | Pharmaceutical formulation containing tolterodine and its use |
DE19955190A1 (de) * | 1999-11-16 | 2001-06-21 | Sanol Arznei Schwarz Gmbh | Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen |
SE9904850D0 (sv) * | 1999-12-30 | 1999-12-30 | Pharmacia & Upjohn Ab | Novel process and intermediates |
WO2001070689A1 (fr) | 2000-03-24 | 2001-09-27 | Meiji Seika Kaisha, Ltd. | DERIVES DE LA DIPHENYLALKYLAMINE UTILES COMME AGONISTES DU RECEPTEUR DE L'OPIOIDE $g(d) |
DE10028443C1 (de) * | 2000-06-14 | 2002-05-29 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen |
DE10033016A1 (de) | 2000-07-07 | 2002-01-24 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von 3,3-Diarylpropylaminen |
PE20020547A1 (es) | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
NZ528377A (en) * | 2001-03-27 | 2005-05-27 | Galen Chemicals Ltd | Intravaginal drug delivery devices for the administration of an antimicrobial agent |
US20030027856A1 (en) * | 2001-06-29 | 2003-02-06 | Aberg A.K. Gunnar | Tolterodine metabolites |
US20030060513A1 (en) * | 2001-09-27 | 2003-03-27 | Arneric Stephen P. | Pharmaceutical composition |
SG168451A1 (en) * | 2001-10-26 | 2011-02-28 | Upjohn Co | Quarternary ammonium compounds and their use as antimuscarinic agents |
EP1441706A2 (en) * | 2001-11-05 | 2004-08-04 | Pharmacia & Upjohn Company | Antimuscarinic aerosol |
CA2466336A1 (en) * | 2001-11-09 | 2003-05-15 | Ebrahim Versi | Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
WO2003053428A1 (en) * | 2001-12-20 | 2003-07-03 | Pharmacia Corporation | Controlled release dosage form having improved drug release properties |
JP4625637B2 (ja) | 2002-02-22 | 2011-02-02 | シャイア エルエルシー | 活性物質送達系及び活性物質を保護し投与する方法 |
US7005449B2 (en) * | 2002-04-23 | 2006-02-28 | Pharmacia & Upjohn Company | Tolterodine salts |
AU2002345266B2 (en) * | 2002-07-08 | 2009-07-02 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
US7825132B2 (en) | 2002-08-23 | 2010-11-02 | Novartis Vaccines And Diagnostics, Inc. | Inhibition of FGFR3 and treatment of multiple myeloma |
JP2006511616A (ja) | 2002-11-13 | 2006-04-06 | カイロン コーポレイション | 癌の処置方法およびその関連方法 |
DE10315917A1 (de) * | 2003-04-08 | 2004-11-18 | Schwarz Pharma Ag | Hochreine Basen von 3,3-Diphenylpropylaminmonoestern |
WO2004089898A1 (en) * | 2003-04-09 | 2004-10-21 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
US20070021487A1 (en) * | 2003-04-11 | 2007-01-25 | Mohammad Salman | Azabicyclo derivatives as muscarinic receptor antagonists |
WO2004096751A1 (en) | 2003-04-25 | 2004-11-11 | Pharmacia & Upjohn Company Llc | Halogen substituted 3,3-diphenylpropylamines (tolterodine) having antimuscarinic activity |
JP2007502865A (ja) * | 2003-05-23 | 2007-02-15 | ブリッジ ファーマ、インコーポレイテッド | 平滑筋鎮痙剤 |
WO2005012227A2 (en) * | 2003-08-05 | 2005-02-10 | Ranbaxy Laboratories Limited | Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine |
ES2235648B1 (es) * | 2003-12-22 | 2006-11-01 | Ragactives, S.L. | Procedimiento para la obtencion de tolterodina. |
KR101154023B1 (ko) * | 2003-12-24 | 2012-06-07 | 씨아이피엘에이 엘티디. | 톨테로딘, 그 조성물 및 용도, 그리고 그 제조방법 |
AU2005216904B2 (en) | 2004-02-20 | 2010-11-25 | Novartis Vaccines And Diagnostics, Inc. | Modulation of inflammatory and metastatic processes |
EP1629834A1 (en) | 2004-08-27 | 2006-03-01 | KRKA, D.D., Novo Mesto | Sustained release pharmaceutical composition of tolterodine |
US20100035954A1 (en) * | 2004-12-15 | 2010-02-11 | Mohammad Salman | Acid addition salts of muscarinic receptor antagonists |
WO2006074479A1 (en) * | 2005-01-10 | 2006-07-13 | Teva Pharmaceutical Industries, Ltd. | Process for preparing tolterodine tartrate |
WO2006117754A1 (en) * | 2005-05-03 | 2006-11-09 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
KR101319122B1 (ko) | 2005-05-13 | 2013-10-23 | 노파르티스 아게 | 약물 저항성 암을 치료하는 방법 |
RU2008120332A (ru) * | 2005-12-20 | 2010-01-27 | Пфайзер Продактс Инк. (Us) | Фармацевтическая композиция для лечения luts, содержащая ингибитор pde5 и мускариновый антагонист |
CA2643097C (en) | 2006-03-20 | 2012-03-13 | Pfizer Limited | Amine derivatives |
KR101453318B1 (ko) * | 2006-05-31 | 2014-10-21 | 유씨비 매뉴팩처링 아일랜드 리미티드 | 치환 히드록시메틸 페놀의 새로운 합성 |
EP1862449A1 (en) * | 2006-05-31 | 2007-12-05 | Schwarz Pharma Ltd. | A shortened synthesis of substituted hydroxymethyl phenols |
IES20060424A2 (en) * | 2006-06-08 | 2007-10-31 | Schwarz Pharma Ltd | Accelerated synthesis of (3-Diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol and its phenolic monoesters |
DE602007008389D1 (de) | 2006-06-09 | 2010-09-23 | Schwarz Pharma Ltd | Synthese von phenolischen estern von hydroxymethylphenolen |
IES20060435A2 (en) | 2006-06-12 | 2007-12-12 | Schwarz Pharma Ltd | Shortened synthesis using paraformaldehyde or trioxane |
KR101488740B1 (ko) | 2006-06-12 | 2015-02-03 | 유씨비 파마 게엠베하 | 새로운 키랄 중간체, 그 키랄 중간체의 제조방법 및 톨테로딘, 페소테로딘 또는 그 활성대사물질의 제조에서 그키랄 중간체의 사용 |
EP2044001B1 (en) | 2006-06-20 | 2016-11-23 | LEK Pharmaceuticals d.d. | Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-n-alkyl-3-phenylpropylamines |
US20100217034A1 (en) * | 2007-09-21 | 2010-08-26 | Actavis Group Ptc Ehf | Process for the Preparation of Fesoterodine |
KR101188333B1 (ko) * | 2008-02-20 | 2012-10-09 | 에스케이케미칼주식회사 | 안정성이 우수하고 경피제로 유용한 톨테로딘 결정성산부가염 |
US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
CA2761602C (en) * | 2009-05-11 | 2015-07-07 | Ratiopharm Gmbh | Desfesoterodine in the form of a tartaric acid salt |
IT1394217B1 (it) | 2009-05-15 | 2012-06-01 | Chemi Spa | Metodo di preparazione di fesoterodina e/o fesoterodina fumarato. |
IT1394219B1 (it) | 2009-05-15 | 2012-06-01 | Chemi Spa | Metodo di preparazione di fesoterodina fumarato di elevata purezza. |
EP2281801B1 (en) | 2009-07-27 | 2014-01-08 | Crystal Pharma, S.A.U. | Process for obtaining 3,3-diphenylpropylamines |
IT1396373B1 (it) * | 2009-10-29 | 2012-11-19 | Dipharma Francis Srl | Procedimento per la preparazione di fesoterodina. |
IL210279A0 (en) | 2009-12-25 | 2011-03-31 | Dexcel Pharma Technologies Ltd | Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients |
EP2364966A1 (en) | 2010-03-09 | 2011-09-14 | LEK Pharmaceuticals d.d. | Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine |
WO2011141932A2 (en) | 2010-05-11 | 2011-11-17 | Intas Pharmaceuticals Limited | Process for preparation of phenolic monoesters of hydroxymethyl phenols |
WO2011145019A1 (en) * | 2010-05-17 | 2011-11-24 | Orchid Chemicals And Pharmaceuticals Limited | Improved process for diphenylpropylamine derivatives |
IT1401451B1 (it) | 2010-06-10 | 2013-07-26 | Chemi Spa | Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo. |
IT1403094B1 (it) | 2010-12-09 | 2013-10-04 | Dipharma Francis Srl | Procedimento per la preparazione di fesoterodina o un suo sale |
TWI590821B (zh) | 2011-01-18 | 2017-07-11 | 輝瑞有限公司 | 固體分子分散液 |
JP6234999B2 (ja) | 2012-05-04 | 2017-11-22 | クリスタル ファルマ、エセ、ア、ウCrystal Pharma,S.A.U. | 光学的に活性な3,3−ジフェニルプロピルアミンを調製するための方法 |
US9315450B2 (en) | 2012-06-14 | 2016-04-19 | Ratiopharm Gmbh | Desfesoterodine salts |
ITMI20121232A1 (it) | 2012-07-16 | 2014-01-17 | Cambrex Profarmaco Milano Srl | Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati |
GB201402556D0 (en) | 2014-02-13 | 2014-04-02 | Crystec Ltd | Improvements relating to inhalable particles |
WO2016148444A1 (ko) * | 2015-03-17 | 2016-09-22 | 제이더블유중외제약 주식회사 | 신규 데스페소테로딘 유도체, 이의 약제학적으로 허용되는 염 및 이를 포함하는 약제학적 조성물 |
WO2017137955A1 (en) | 2016-02-14 | 2017-08-17 | Celestis Pharmaceuticals Pvt. Ltd. | Novel (r) and rac 3-(2-(allyloxy)-5-methylphenyl)-n,n-diisopropyl-3- phenylpropan-1-amine and its use for synthesis of (r) and rac-2-(3- (diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol |
CN110372571B (zh) | 2018-04-12 | 2022-11-15 | 中国科学院大连化学物理研究所 | 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK111894A (no) | 1962-11-15 | |||
GB1169945A (en) | 1966-08-25 | 1969-11-05 | Geistlich Soehne Ag | Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives |
GB1169944A (en) | 1966-08-25 | 1969-11-05 | Geistlich Soehne Ag | Novel 3,3-Diphenylpropylamines and processes for the preparation thereof |
US4139537A (en) | 1976-06-29 | 1979-02-13 | Cooper Laboratories, Inc. | 3-Aryloxy-1-(2- or 4-iminodihydro-1-pyridyl)-2-propanol antiarrhythmic compounds |
SE8800207D0 (sv) | 1988-01-22 | 1988-01-22 | Kabivitrum Ab | Nya aminer, deras anvendning och framstellning |
US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
SE9203318D0 (sv) * | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
US5472958A (en) * | 1994-08-29 | 1995-12-05 | Abbott Laboratories | 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function |
PE20020547A1 (es) * | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
-
1992
- 1992-11-06 SE SE9203318A patent/SE9203318D0/xx unknown
-
1993
- 1993-11-05 DE DE69317898T patent/DE69317898T2/de not_active Expired - Lifetime
- 1993-11-05 EP EP93924876A patent/EP0667852B1/en not_active Expired - Lifetime
- 1993-11-05 AU AU54380/94A patent/AU672458B2/en not_active Expired
- 1993-11-05 WO PCT/SE1993/000927 patent/WO1994011337A1/en active IP Right Grant
- 1993-11-05 AT AT93924876T patent/ATE164828T1/de active
- 1993-11-05 CA CA002148827A patent/CA2148827C/en not_active Expired - Lifetime
- 1993-11-05 JP JP51197794A patent/JP3343256B2/ja not_active Expired - Lifetime
- 1993-11-05 US US11/017,635 patent/USRE39667E1/en not_active Expired - Lifetime
- 1993-11-05 HU HU9501329A patent/HU224916B1/hu unknown
- 1993-11-05 ES ES93924876T patent/ES2117155T3/es not_active Expired - Lifetime
- 1993-11-05 US US11/402,337 patent/USRE40851E1/en not_active Expired - Lifetime
- 1993-11-05 DK DK93924876T patent/DK0667852T3/da active
-
1995
- 1995-05-05 NO NO951775A patent/NO305477B1/no not_active IP Right Cessation
- 1995-05-05 FI FI952179A patent/FI120256B/fi not_active IP Right Cessation
- 1995-05-05 US US08/432,113 patent/US5559269A/en not_active Ceased
-
1996
- 1996-07-22 US US08/684,638 patent/US5686464A/en not_active Expired - Lifetime
-
1998
- 1998-06-17 HK HK98105466A patent/HK1006349A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0667852B1 (en) | 1998-04-08 |
FI952179A0 (fi) | 1995-05-05 |
ES2117155T3 (es) | 1998-08-01 |
FI120256B (fi) | 2009-08-31 |
DE69317898T2 (de) | 1998-10-15 |
JP3343256B2 (ja) | 2002-11-11 |
CA2148827A1 (en) | 1994-05-26 |
AU672458B2 (en) | 1996-10-03 |
DE69317898D1 (de) | 1998-05-14 |
ATE164828T1 (de) | 1998-04-15 |
DK0667852T3 (da) | 1999-01-11 |
AU5438094A (en) | 1994-06-08 |
US5686464A (en) | 1997-11-11 |
HU9501329D0 (en) | 1995-06-28 |
NO951775L (no) | 1995-05-05 |
CA2148827C (en) | 2005-01-04 |
EP0667852A1 (en) | 1995-08-23 |
FI952179A (fi) | 1995-05-05 |
USRE40851E1 (en) | 2009-07-14 |
NO305477B1 (no) | 1999-06-07 |
HK1006349A1 (en) | 1999-02-19 |
USRE39667E1 (en) | 2007-05-29 |
US5559269A (en) | 1996-09-24 |
HUT72742A (en) | 1996-05-28 |
SE9203318D0 (sv) | 1992-11-06 |
JPH08503208A (ja) | 1996-04-09 |
HU224916B1 (en) | 2006-04-28 |
WO1994011337A1 (en) | 1994-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO951775D0 (no) | Nye 3,3-difenylpropylaminer, deres anvendelse og fremstilling | |
ES2029384T3 (es) | Procedimiento para preparar nuevas 3,3-difenilpropilaminas. | |
ZA932168B (en) | Naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them | |
AU4616893A (en) | New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them | |
BR1100061A (pt) | Composto, processo para a preparação do mesmo, composição e uso dos mesmos | |
HK1023346A1 (en) | Novel substituted tetrahyropyridine derivatives, method of preparation and pharmaceutical compositions containing them | |
AU5511394A (en) | New (cyclohexyl)alkene compounds, processes for preparing them and pharmaceutical compositions containing them | |
AU659738B2 (en) | New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |